Topics
5-alpha-reductaseBiomolecule
benign prostate hyperplasiaDisease
Background This nationwide population-based study investigated the risk of cardiovascular diseases after 5-alpha-reductase inhibitor therapy for benign prostate hyperplasia (BPH) using th
International audienceBenign prostate hypertrophy (BPH) could be associated with low urinary symptom...
Angela B Smith, Culley C CarsonUniversity of North Carolina Division of Urologic Surgery, Chapel Hil...
5-alpha reductase inhibitors (5-ARI) have been suggested to increase the risk of male breast cancer....
This nationwide population-based study investigated the risk of cardiovascular diseases after 5-alph...
This nationwide population-based study investigated the risk of cardiovascular diseases after 5-alph...
Several studies suggest that 5-alpha reductase inhibitors (5ARIs) may be associated with elevated ri...
Item does not contain fulltextOBJECTIVE: To investigate whether there is a difference in the risk of...
Item does not contain fulltextOBJECTIVE: Given the high possibility of co-occurrence of benign prost...
Objective: To investigate whether there is a difference in the risk of progressing to BPH-related pr...
PURPOSE OF REVIEW: The use of 5-alpha reductase inhibitors (5ARIs) for the treatment of benign prost...
Purpose: The medical treatment for benign prostatic hyperplasia (BPH) had recently been directed at ...
Olulade Ayodele,1 Howard J Cabral,2,3 David McManus,4 Susan Jick1,5 1Department of Epidemiology, Bos...
Objective: Given the high possibility of co-occurrence of benign prostatic hyperplasia (BPH) and car...
International audienceObjective - To assess the association between 5α-reductase inhibitor (5-ARI) u...
International audienceBenign prostate hypertrophy (BPH) could be associated with low urinary symptom...
Angela B Smith, Culley C CarsonUniversity of North Carolina Division of Urologic Surgery, Chapel Hil...
5-alpha reductase inhibitors (5-ARI) have been suggested to increase the risk of male breast cancer....
This nationwide population-based study investigated the risk of cardiovascular diseases after 5-alph...
This nationwide population-based study investigated the risk of cardiovascular diseases after 5-alph...
Several studies suggest that 5-alpha reductase inhibitors (5ARIs) may be associated with elevated ri...
Item does not contain fulltextOBJECTIVE: To investigate whether there is a difference in the risk of...
Item does not contain fulltextOBJECTIVE: Given the high possibility of co-occurrence of benign prost...
Objective: To investigate whether there is a difference in the risk of progressing to BPH-related pr...
PURPOSE OF REVIEW: The use of 5-alpha reductase inhibitors (5ARIs) for the treatment of benign prost...
Purpose: The medical treatment for benign prostatic hyperplasia (BPH) had recently been directed at ...
Olulade Ayodele,1 Howard J Cabral,2,3 David McManus,4 Susan Jick1,5 1Department of Epidemiology, Bos...
Objective: Given the high possibility of co-occurrence of benign prostatic hyperplasia (BPH) and car...
International audienceObjective - To assess the association between 5α-reductase inhibitor (5-ARI) u...
International audienceBenign prostate hypertrophy (BPH) could be associated with low urinary symptom...
Angela B Smith, Culley C CarsonUniversity of North Carolina Division of Urologic Surgery, Chapel Hil...
5-alpha reductase inhibitors (5-ARI) have been suggested to increase the risk of male breast cancer....
Add to ORKG